Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.5M Buy
217,500
+153,500
+240% +$5.7M 0.05% 84
2026
Q1
$2.56M Sell
64,000
-40,600
-39% -$1.92M 0.03% 131
2025
Q4
$4.7M Sell
104,600
-17,099
-14% -$791K 0.09% 72
2025
Q3
$5.44M Buy
121,699
+107,099
+734% +$5.13M 0.15% 58
2025
Q2
$702K Sell
14,600
-100
-0.7% -$4.35K 0.03% 111
2025
Q1
$590K Buy
+14,700
New +$618K 0.02% 154

Other funds holding QGEN

SIH Partners's QGEN Position: Q2 2026 in Review

SIH Partners increased its Qiagen (QGEN) stake by 66% in Q2 2026, buying an estimated $848K and bringing the position to 57,242 shares worth $2.24M. The position accounts for 0.01% of the portfolio, ranked #154.

SIH Partners first reported a position in QGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.09M in Q2 2025. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • SIH Partners held 57,242 shares of Qiagen worth $2.24M as of Q2 2026.
  • SIH Partners bought 22,824 Qiagen shares in Q2 2026, an estimated $848K.
  • Qiagen made up 0.01% of SIH Partners's portfolio in Q2 2026, its #154 holding.
  • SIH Partners first reported a position in Qiagen in Q4 2024 and has held it in 7 quarters since.
  • SIH Partners's Qiagen position peaked at $4.09M in Q2 2025.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.